Petr obtained his Bachelor’s and Master’s degrees in Finance from the Prague University of Economics and Business and is currently pursuing an Executive MBA at ESADE Business School in Barcelona.

Before joining Ability Pharmaceuticals, he held various financial and general management roles, including Finance Director, Managing Director, and Interim General Manager, at several companies in the Czech Republic. During this time, he successfully led company expansions, executed strategic investments, built and managed teams, tackled transformation challenges, and oversaw complex business transitions. He also managed strategic M&A activities, including comprehensive due diligence and post-acquisition integration processes.

After relocating to Spain, Petr worked for a strategic consulting and financial advisory firm specializing in the Life Sciences sector, where he served as Head of the Life Sciences Business Unit and Head of Operations.

In 2024, Petr joined Ability Pharmaceuticals as Chief Financial Officer (CFO).

• 

  CFO: Chief Financial Officer in Ability Pharma

  AbilityPharma is a clinical stage phase 2b biopharmaceutical company focused on autophagy to treat cancer